136 related articles for article (PubMed ID: 19879926)
1. Alpha-synuclein deficiency in the C57BL/6JOlaHsd strain does not modify disease progression in the ME7-model of prion disease.
Asuni AA; Hilton K; Siskova Z; Lunnon K; Reynolds R; Perry VH; O'Connor V
Neuroscience; 2010 Feb; 165(3):662-74. PubMed ID: 19879926
[TBL] [Abstract][Full Text] [Related]
2. An integrated, temporal study of the behavioural, electrophysiological and neuropathological consequences of murine prion disease.
Chiti Z; Knutsen OM; Betmouni S; Greene JR
Neurobiol Dis; 2006 May; 22(2):363-73. PubMed ID: 16431123
[TBL] [Abstract][Full Text] [Related]
3. Neuropathologically distinct prion strains give rise to similar temporal profiles of behavioral deficits.
Cunningham C; Deacon RM; Chan K; Boche D; Rawlins JN; Perry VH
Neurobiol Dis; 2005 Mar; 18(2):258-69. PubMed ID: 15686954
[TBL] [Abstract][Full Text] [Related]
4. Onset of accumulation of PrPres in murine ME7 scrapie in relation to pathological and PrP immunohistochemical changes.
Jeffrey M; Martin S; Barr J; Chong A; Fraser JR
J Comp Pathol; 2001 Jan; 124(1):20-8. PubMed ID: 11428185
[TBL] [Abstract][Full Text] [Related]
5. Loss of Perineuronal Net in ME7 Prion Disease.
Franklin SL; Love S; Greene JR; Betmouni S
J Neuropathol Exp Neurol; 2008 Mar; 67(3):189-99. PubMed ID: 18344910
[TBL] [Abstract][Full Text] [Related]
6. Differences in extinction of conditioned fear in C57BL/6 substrains are unrelated to expression of alpha-synuclein.
Siegmund A; Langnaese K; Wotjak CT
Behav Brain Res; 2005 Feb; 157(2):291-8. PubMed ID: 15639180
[TBL] [Abstract][Full Text] [Related]
7. Alpha-synuclein-immunoreactive deposits in human and animal prion diseases.
Haïk S; Privat N; Adjou KT; Sazdovitch V; Dormont D; Duyckaerts C; Hauw JJ
Acta Neuropathol; 2002 May; 103(5):516-20. PubMed ID: 11935269
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and alpha-synuclein-deleted mice.
Alvarez-Fischer D; Henze C; Strenzke C; Westrich J; Ferger B; Höglinger GU; Oertel WH; Hartmann A
Exp Neurol; 2008 Mar; 210(1):182-93. PubMed ID: 18053987
[TBL] [Abstract][Full Text] [Related]
9. MCP-1 and murine prion disease: separation of early behavioural dysfunction from overt clinical disease.
Felton LM; Cunningham C; Rankine EL; Waters S; Boche D; Perry VH
Neurobiol Dis; 2005 Nov; 20(2):283-95. PubMed ID: 15886005
[TBL] [Abstract][Full Text] [Related]
10. Epitope scanning reveals gain and loss of strain specific antibody binding epitopes associated with the conversion of normal cellular prion to scrapie prion.
Pan T; Li R; Kang SC; Wong BS; Wisniewski T; Sy MS
J Neurochem; 2004 Sep; 90(5):1205-17. PubMed ID: 15312175
[TBL] [Abstract][Full Text] [Related]
11. Abnormal synaptic protein expression and cell death in murine scrapie.
Sisó S; Puig B; Varea R; Vidal E; Acín C; Prinz M; Montrasio F; Badiola J; Aguzzi A; Pumarola M; Ferrer I
Acta Neuropathol; 2002 Jun; 103(6):615-26. PubMed ID: 12012094
[TBL] [Abstract][Full Text] [Related]
12. Change in tau phosphorylation associated with neurodegeneration in the ME7 model of prion disease.
Asuni AA; Perry VH; O'Connor V
Biochem Soc Trans; 2010 Apr; 38(2):545-51. PubMed ID: 20298219
[TBL] [Abstract][Full Text] [Related]
13. Neuropil and neuronal changes in hippocampal NADPH-diaphorase histochemistry in the ME7 model of murine prion disease.
Picanço-Diniz CW; Boche D; Gomes-Leal W; Perry VH; Cunningham C
Neuropathol Appl Neurobiol; 2004 Jun; 30(3):292-303. PubMed ID: 15175082
[TBL] [Abstract][Full Text] [Related]
14. Re-transmissibility of mouse-adapted ME7 scrapie strain to ovine PrP transgenic mice.
Babalola JA; Kim JM; Lee YJ; Park JH; Choi HS; Choi YG; Choi EK; Kim YS
J Vet Sci; 2019 Mar; 20(2):e8. PubMed ID: 30944531
[TBL] [Abstract][Full Text] [Related]
15. Reduced expression of the presynaptic co-chaperone cysteine string protein alpha (CSPα) does not exacerbate experimentally-induced ME7 prion disease.
Davies MJ; Cooper M; Perry VH; O'Connor V
Neurosci Lett; 2015 Mar; 589():138-43. PubMed ID: 25623034
[TBL] [Abstract][Full Text] [Related]
16. In vivo toxicity of prion protein in murine scrapie: ultrastructural and immunogold studies.
Jeffrey M; Goodsir CM; Bruce ME; McBride PA; Fraser JR
Neuropathol Appl Neurobiol; 1997 Apr; 23(2):93-101. PubMed ID: 9160894
[TBL] [Abstract][Full Text] [Related]
17. Transmission of prion strains in a transgenic mouse model overexpressing human A53T mutated α-synuclein.
Mougenot AL; Bencsik A; Nicot S; Vulin J; Morignat E; Verchère J; Bétemps D; Lakhdar L; Legastelois S; Baron TG
J Neuropathol Exp Neurol; 2011 May; 70(5):377-85. PubMed ID: 21487306
[TBL] [Abstract][Full Text] [Related]
18. Alkaline hydrolysis of mouse-adapted scrapie for inactivation and disposal of prion-positive material.
Murphy RG; Scanga JA; Powers BE; Pilon JL; Vercauteren KC; Nash PB; Smith GC; Belk KE
J Anim Sci; 2009 May; 87(5):1787-93. PubMed ID: 19098230
[TBL] [Abstract][Full Text] [Related]
19. α-Synuclein deficiency and efferent nerve degeneration in the mouse cochlea: a possible cause of early-onset presbycusis.
Park SN; Back SA; Choung YH; Kim HL; Akil O; Lustig LR; Park KH; Yeo SW
Neurosci Res; 2011 Nov; 71(3):303-10. PubMed ID: 21840348
[TBL] [Abstract][Full Text] [Related]
20. Synaptic plasticity in the CA1 area of the hippocampus of scrapie-infected mice.
Johnston AR; Fraser JR; Jeffrey M; MacLeod N
Neurobiol Dis; 1998 Sep; 5(3):188-95. PubMed ID: 9848090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
